JLVRX
Price
$20.66
Change
-$0.13 (-0.63%)
Updated
Dec 17 closing price
RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
Ad is loading...

JLVRX vs RMFCX

Header iconJLVRX vs RMFCX Comparison
Open Charts JLVRX vs RMFCXBanner chart's image
JPMorgan Large Cap Value R5
Price$20.66
Change-$0.13 (-0.63%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
JLVRX vs RMFCX Comparison Chart
Loading...
View a ticker or compare two or three
VS
JLVRX vs. RMFCX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JLVRX is a Hold and RMFCX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. JLVRX (5.06B). RMFCX (1.69) and JLVRX (1.61) have matching dividends . JLVRX was incepted earlier than RMFCX: JLVRX (19 years) vs RMFCX (23 years). JLVRX is a more actively managed with annual turnover of: 143.00 vs. RMFCX (25.00). JLVRX has a lower initial minimum investment than RMFCX: JLVRX (0) vs RMFCX (250). RMFCX annual gain was more profitable for investors over the last year : 12.63 vs. JLVRX (10.58). JLVRX return over 5 years is better than : 43.38 vs. RMFCX (40.39).
JLVRXRMFCXJLVRX / RMFCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years23 years-
Gain YTD9.58411.42384%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets5.06B104B5%
Annual Yield % from dividends1.611.6995%
Returns for 1 year10.5812.6384%
Returns for 3 years15.8814.16112%
Returns for 5 years43.3840.39107%
Returns for 10 years56.7861.8492%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc